Porton Fine Chemicals Ltd (300363):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Porton Fine Chemicals Ltd (300363) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8263
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Porton Fine Chemicals Ltd (Porton) is a supplier of custom drug intermediates and active pharmaceutical ingredients. The company provides custom and contract chemical development, and contract manufacturing services. It provides products such as reactive reagents, chiral chromatography products, unnatural amino acids and heterocylics, among others. Porton also offers regulatory support for the commercialization of active pharmaceutical ingredients and intermediates of APIs. The company offers biocatalysis, process intensification and process safety laboratory. It operates in China, Belgium and the US. Porton is headquartered in Chongqing, China.

Porton Fine Chemicals Ltd (300363) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
BioDuro Enters into Agreement with Porton Pharma Solutions 10
Debt Offering 11
Porton Fine Chemicals Plans to Raise up to USD71 Million in Private Placement of Notes 11
Acquisition 12
Porton Fine Chemicals Acquires J-Star Research for USD26 Million 12
Porton Fine Chemicals Plans to Acquire Jiangxi Dongbang Pharma for USD42 Million 13
Porton Fine Chemicals Ltd – Key Competitors 14
Porton Fine Chemicals Ltd – Key Employees 15
Porton Fine Chemicals Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Porton Fine Chemicals Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BioDuro Enters into Agreement with Porton Pharma Solutions 10
Porton Fine Chemicals Plans to Raise up to USD71 Million in Private Placement of Notes 11
Porton Fine Chemicals Acquires J-Star Research for USD26 Million 12
Porton Fine Chemicals Plans to Acquire Jiangxi Dongbang Pharma for USD42 Million 13
Porton Fine Chemicals Ltd, Key Competitors 14
Porton Fine Chemicals Ltd, Key Employees 15
Porton Fine Chemicals Ltd, Subsidiaries 16

List of Figures
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Porton Fine Chemicals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Porton Fine Chemicals Ltd (300363):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Amarillo Biosciences Inc (AMAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Amarillo Biosciences Inc (ABI) is a specialty biopharmaceutical company, which focuses on the development of biologics for the treatment of human and animal diseases. It develops innovative therapeutic candidates for the treatment of human disease indications such as influenza, hepatitis C, …
  • Just Energy Group Inc. (JE)-エネルギー分野:企業M&A・提携分析
    Summary Just Energy Group Inc. (Just Energy) is a provider of energy management solutions. The company offers natural gas, electricity, solar energy, green energy and energy efficiency tools and products to customers. It serves consumer and commercial markets through fixed price contracts, variable- …
  • Fairfax Media Limited:企業の戦略・SWOT・財務情報
    Fairfax Media Limited - Strategy, SWOT and Corporate Finance Report Summary Fairfax Media Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cathay Pacific Airways Limited:企業のM&A・事業提携・投資動向
    Cathay Pacific Airways Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cathay Pacific Airways Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Stellar Resources Ltd:企業の戦略・SWOT・財務分析
    Stellar Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Stellar Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Aksigorta A.S. (AKGRT):企業の財務・戦略的SWOT分析
    Aksigorta A.S. (AKGRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Novanta Inc (NOVT):医療機器:M&Aディール及び事業提携情報
    Summary Novanta Inc (Novanta), formerly GSI Group Inc is a medical device company that manufactures and markets precision photonics, motion control components and subsystems. The company provides laser products, medical technologies, and precision motion products. It offers laser sources and beam de …
  • Kala Pharmaceuticals Inc (KALA):製薬・医療:M&Aディール及び事業提携情報
    Summary Kala Pharmaceuticals Inc (Kala Pharmaceuticals) is a clinical stage pharmaceutical company that offers nanoparticle-based treatments for ocular diseases affecting both front and back of the eye. The company’s lead program MPP nanosuspension of an ophthalmic corticosteroid is under phase III …
  • Alfred E. Tiefenbacher (GmbH & Co KG)-製薬・医療分野:企業M&A・提携分析
    Summary Alfred E. Tiefenbacher (GmbH & Co KG) (AET) is a healthcare products provider that develops active pharmaceuticals ingredients. The company’s products comprise cytotoxic drugs, hormones, OTC drugs, controlled drugs, herbal drugs, high potent drugs, new combination products, inhaler technolog …
  • HD Biosciences (China) Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary HD Biosciences (China) Co Ltd (HDB), a subsidiary of WuXi AppTec (Shanghai) Co Ltd, is a contract research organization that offers drug discovery research services. The organization develops and provides products such as mycoplasma detection kit and wash free calcium assay kit, among others …
  • The Arab Assurers Insurance Co.:企業の戦略・SWOT・財務情報
    The Arab Assurers Insurance Co. - Strategy, SWOT and Corporate Finance Report Summary The Arab Assurers Insurance Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • China Huaneng Group:企業の発電所・SWOT分析2018
    China Huaneng Group - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Meiji Holdings Co, Ltd.
    Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • One Way Liver SL-製薬・医療分野:企業M&A・提携分析
    Summary One Way Liver SL (OWL), formerly One Way Liver Genomics SL is a biotechnology company that discovers, develops and offers diagnostic products and metabolomics services for the healthcare sector. The company commercializes OWLiver, which is a serum based test used for steatosis and NASH diagn …
  • Onconova Therapeutics Inc (ONTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Onconova Therapeutics Inc (Onconova) is a biopharmaceutical company that discovers and develops small molecule drug candidates for the treatment of cancer. The company’s drug candidates include rigosertib, briciclib and recilisib. It develops drug candidates that target cancer and protect he …
  • Acome:企業の戦略・SWOT・財務情報
    Acome - Strategy, SWOT and Corporate Finance Report Summary Acome - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Mediacom Communications Corp:企業の戦略的SWOT分析
    Mediacom Communications Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Juntendo University-製薬・医療分野:企業M&A・提携分析
    Summary Juntendo University (Juntendo) is a healthcare service provider that offers medical education and research services. The institute offers medical education, practices and healthcare services which include consultation, nursing, emergency room, and others. Its services comprise radiology, spo …
  • HeartWare International Inc:企業の戦略的SWOT分析
    HeartWare International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Catalent Inc:企業の戦略・SWOT・財務情報
    Catalent Inc - Strategy, SWOT and Corporate Finance Report Summary Catalent Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆